A CBD medicine that fights severe epilepsy in children could become the first medicinal cannabis drug available through the Pharmaceutical Benefits Scheme (PBS).

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

The Pharmaceutical Benefits Advisory Committee (PBAC) will discuss the application for Epidyolex this month with a decision made public on the PBS website around six weeks later.

Steve has reported for a number of consumer and B2B titles over a journalism career spanning more than three decades. He is a regulator contributor to health journal, The Medical Republic, writing on...